Ledger.Open graph →
SEC Form D · Amendment · filed August 7, 2015

Gemphire Therapeutics Inc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NORTHVILLE, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

P. K. Hawryluk · Carmel, INDirectorCharles Bisgaier · Northville, MIExec · DirectorMargaret Mcshane · Northville, MIExecDaniela Oniciu · Northville, MIExecDavid Lowenschuss · Northville, MIExec · DirectorMina Sooch · Northville, MIExec · DirectorKenneth Kousky · Midland, MIDirectorAndy Sassine · Rancho Santa Fe, CADirectorAmir Belson · Menlo Park, CAExec · DirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorKenneth Hood · San Diego, CAExec · DirectorPaul Nasser · BOSTON, MADirectorDeborah L. Machovec · Wahoo, NEDirectorWilliam Alaynick · San Diego, CAExec · DirectorLawrence Chavez · Albuquerque, NMExecHurley Doddy · George Town, Grand Cayman, Cayman IslandsDirectorMarc A. Weiser · Ann Arbor, MIExec · DirectorPravin V. Gandhi · Fort Mumbai, K7Exec · DirectorBala V. Deshpande · Timonium, MDExec · DirectorGeorge A. Parris · Audubon, IAExec · DirectorJon Cheek · SAN FRANCISCO, CAExecJt Michelson · Albuquerque, NMExecAlan I. Bossin · Hamilton, BermudaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗